Next-generation healthy gut microbiome products
Evolve BioSystems, a microbiome company, is developing the next generation of products to establish, restore, and maintain a healthy gut microbiome. The foundation is backing Evolves further development of its lead probiotic Evivo to support healthy growth and development, and prevent infection in infants in developing countries.
- Focus areas
- Agriculture & Nutrition
- Investment type
- Direct equity
- Status
- Active
- Initial investment
- Series C
- Partnered in
- 2018
- Headquarters
- USA
More about our work
Our focus
We embrace science and technology innovations that solve old problems in new ways, challenge status quos, and build on past breakthroughs. Our six domains of focus comprise 40+ program strategies across the foundation’s nearly $9B annual charitable support.
Investment Approach
How the Strategic Investment Fund is fostering partnerships with the private sector to leverage the globe’s most groundbreaking global innovations for societal good.
Our Team
The SIF Investment Committee brings depth of experience to global investment programs, with a proven track record of innovation across sectors and scale.